Erwinia L-asparaginase

DRUG2 trials

Sponsors

Phoenix Children's Hospital, St. Jude Children's Research Hospital

Conditions

Acute Lymphoid LeukemiaAcute Myeloid LeukemiaLeukemia, Acute LymphoblasticMixed Lineage Acute Leukemia

Phase 2

Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies

TerminatedNCT02419755

St. Jude Children's Research HospitalAcute Lymphoid Leukemia, Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia

Start: 2015-04-14End: 2016-12-31Updated: 2018-03-07

Unknown Phase

Erwinase Master Treatment Protocol

Phoenix Children's HospitalAcute Lymphoid Leukemia, Leukemia, Acute Lymphoblastic

Updated: 2026-01-23

Related Papers

Development of Novel Proteasome-HDAC6 Hybrid Inhibitors for Resistant ALL Phenotype

Blood2017-12-07